PDCD1 and gastric cancer: There have been no clinical trials comparing the relationship between H. pylori infection and the efficacy of immunotherapy for gastric cancer; however, a study involving melanoma and colorectal adenocarcinoma mice and non-small cell lung cancer patients found that H. pylori reduced the efficacy of anti-PD-1 immunotherapy [79].